Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 7447

Spring Valley, CA 91978

Study Summary:

A 26-week randomized, confirmatory, controlled, open label, multicenter, multinational treat-to-target trial comparing efficacy and safety of SIBA 200 U/mL three times weekly injected in the morning and insulin glargine once daily in a population of insulin naive subjects with type 2 diabetes mellitus currently treated with oral anti-diabetic drugs (OADs) qualifying for intensified treatment.

Qualified Participants Must:

• Have type 2 diabetes

Qualified Participants May Receive:

Study related medication, diabetes supplies, study-related physician's care and compensation for time and travel/

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.